Literature DB >> 17701187

Ethylenevinylalcohol copolymer (Onyx-18) used in endovascular treatment of vein of Galen malformation.

Anand V Germanwala1, Nirav A Vora, Ajith J Thomas, Tudor Jovin, Yakov Gologorsky, Michael B Horowitz.   

Abstract

BACKGROUND: Vein of Galen malformations (VGM) are rare congenital arteriovenous fistulas that usually present with heart failure in the neonate. Endovascular treatment options in the past have utilized coils, balloons, and acrylics. CASE REPORT: We present, for the first time in the literature, a case of an infant with VGM treated initially with staged coil embolizations followed 1 year later by the transarterial and transvenous catheter based injection of Onyx-18 (ethylenevinylalcohol copolymer) in a single treatment session. The fistula was eliminated, and the infant's cardiopulmonary symptoms were improved.

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 17701187     DOI： 10.1007/s00381-007-0425-3

Source DB:  PubMed          Journal:  Childs Nerv Syst        ISSN： 0256-7040            Impact factor:   1.475


  9 in total

Review 1.  Vein of Galen aneurysms: a review and current perspective.

Authors:  M B Horowitz; C A Jungreis; R G Quisling; I Pollack
Journal:  AJNR Am J Neuroradiol       Date:  1994-09       Impact factor: 3.825

2.  Transfemoral venous embolization of vein of Galen malformations.

Authors:  C F Dowd; V V Halbach; S L Barnwell; R T Higashida; M S Edwards; G B Hieshima
Journal:  AJNR Am J Neuroradiol       Date:  1990 Jul-Aug       Impact factor: 3.825

3.  Endovascular management of vein of Galen aneurysmal malformations presenting in the neonatal period.

Authors:  P J Mitchell; J V Rosenfeld; P Dargaville; P Loughnan; M R Ditchfield; G Frawley; B M Tress
Journal:  AJNR Am J Neuroradiol       Date:  2001-08       Impact factor: 3.825

4.  Embolization of arteriovenous malformations with Onyx: clinicopathological experience in 23 patients.

Authors:  R Jahan; Y Murayama; Y P Gobin; G R Duckwiler; H V Vinters; F Viñuela
Journal:  Neurosurgery       Date:  2001-05       Impact factor: 4.654

5.  Intrasaccular combination of metallic coils and onyx liquid embolic agent for the endovascular treatment of cerebral aneurysms.

Authors:  H Saruhan Cekirge; Isil Saatci; Serdar Geyik; Kivilcim Yavuz; Halil Oztürk; Gülsün Pamuk
Journal:  J Neurosurg       Date:  2006-11       Impact factor: 5.115

Review 6.  Congestive heart failure secondary to cerebral arterio-venous fistula.

Authors:  P A Pellegrino; O Milanesi; O S Saia; C Carollo
Journal:  Childs Nerv Syst       Date:  1987       Impact factor: 1.475

7.  Vein of Galen malformation. Endovascular management of 43 cases.

Authors:  P Lasjaunias; R Garcia-Monaco; G Rodesch; K Ter Brugge; M Zerah; M Tardieu; D de Victor
Journal:  Childs Nerv Syst       Date:  1991-11       Impact factor: 1.475

8.  Complications of preoperative embolization of cerebral arteriovenous malformations.

Authors:  Christopher L Taylor; Kim Dutton; George Rappard; G Lee Pride; Robert Replogle; Phillip D Purdy; Jonathan White; Cole Giller; Thomas A Kopitnik; Duke S Samson
Journal:  J Neurosurg       Date:  2004-05       Impact factor: 5.115

9.  Management of vein of Galen aneurysms. Combined surgical and endovascular approach.

Authors:  W A King; P A Wackym; F Viñuela; W J Peacock
Journal:  Childs Nerv Syst       Date:  1989-08       Impact factor: 1.475
  9 in total
  3 in total

1.  Use of ethylene-vinyl alcohol copolymer as a liquid embolic agent to treat a peripheral arteriovenous malformation in a dog.

Authors:  William T N Culp; Craig B Glaiberman; Rachel E Pollard; Erik R Wisner
Journal:  J Am Vet Med Assoc       Date:  2014-07-15       Impact factor: 1.936

2.  The use of Onyx for embolization of central nervous system arteriovenous lesions in pediatric patients.

Authors:  R Thiex; A Williams; E Smith; R M Scott; D B Orbach
Journal:  AJNR Am J Neuroradiol       Date:  2009-09-12       Impact factor: 3.825

3.  Adjuvant Coil Assisted Glue Embolization of Vein of Galen Aneurysmal Malformation in Pediatric Patients.

Authors:  Dong Joon Kim; Dae Chul Suh; Byung Moon Kim; Dong Ik Kim
Journal:  Neurointervention       Date:  2018-03-02
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.